Mazen Noureddin, MD, MHSc joins HepaTx's Scientific Advisory Board
/PRNewswire/ -- HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced today that Mazen Noureddin, MD, MHSc,...
Source: prnewswire.com